MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Proceedings of the National Academy of Sciences

Topics

Biology

Cancer Oncology

Medicine

Surgery

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1073/pnas.0710370104

Other Formats

PDF